Clinical Study

Phase I Study To Evaluate The Feasibility Of Neoadjuvant Stereotactic Body Radiation Therapy For Resectable Adenocarcinoma Of The Pancreatic Head And/Or Body

Posted Date: May 16, 2018

  • Investigator: Jordan Kharofa
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology, Pancreatic Disease
  • Type of Study: Drug

The purpose of this research study is to test the safety of focused radiation (SBRT) and see what effects (good and bad) it has on patients and their pancreas cancer that will be removed surgically.

Criteria:

To Be Eligible For This Study, You Must Have Been Diagnosed With Pancreas Cancer That Can Be Removed Surgically

Keywords:

Ucci-Gi-002, Head And Neck, Pancreas , Gi, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.